Regeneron Pharmaceuticals has announced that its Phase 3 QUASAR trial evaluating EYLEA HD (afliberce...

Aurion Biotech has released topline data from its Phase 1/2 clinical trial (CLARA), evaluating AURN0...

FDA has cleared the investigational new drug (IND) application for VG801, ViGeneron’s novel gene the...

Viridian Therapeutics has announced positive topline results from the Phase 3 THRIVE-2 clinical tria...

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued...

eyeDNA Therapeutics, a newly created subsidiary of Coave Therapeutics (‘Coave’), has announced that ...

The European Medicines Agency (EMA) has approved Roche's Vabysmo (faricimab) 6.0 mg single-dose pref...

Atsena Therapeutics has successfully completed dosing in Part A of the LIGHTHOUSE study, a Phase I/I...

Phenocell SAS and Amarna Therapeutics have been awarded the prestigious Eurostars grant to advance t...

ACELYRIN has announced that the Phase 2b/3 clinical trial evaluating izokibep for non-infectious, no...